Dementia Que bank

Question 1
Which of the following cognitive symptoms is commonly associated with early-stage dementia?

A) Sudden onset of paralysis
B) Memory loss, particularly difficulty remembering recent events
C) Severe headaches
D) Auditory hallucinations
E) Tremors

---

Question 2
A patient with dementia is experiencing confusion about time and place, often getting lost in familiar areas. Which symptom category does this belong to?

A) Cognitive symptoms
B) Behavioral and psychological symptoms
C) Physical symptoms
D) Functional impairments
E) None of the above

---

Question 3
Which of the following is a behavioral and psychological symptom of dementia?

A) Impaired judgment and decision-making
B) Motor function decline and balance issues
C) Paranoia and hallucinations
D) Difficulty with daily activities like dressing and bathing
E) Memory loss

---

Question 4
A patient with dementia is showing increased agitation and inappropriate behavior. Which symptom category does this belong to?

A) Cognitive symptoms
B) Behavioral and psychological symptoms
C) Physical symptoms
D) Functional impairments
E) None of the above

---

Question 5
Which of the following physical symptoms might indicate the progression of dementia?

A) Sleep disturbances and incontinence
B) Communication difficulties and memory loss
C) Paranoia and hallucinations
D) Impaired judgment and attention issues
E) Social withdrawal and apathy

---

Question 6
A patient with dementia is struggling with tasks like dressing, bathing, and managing personal hygiene. Which symptom category does this belong to?

A) Cognitive symptoms
B) Behavioral and psychological symptoms
C) Physical symptoms
D) Functional impairments
E) None of the above

---

Question 7
What is the primary mechanism of action of donepezil in the treatment of Alzheimer’s disease?

A) Inhibition of NMDA receptors
B) Enhancement of dopamine release
C) Reversible inhibition of acetylcholine esterase
D) Blocking of GABA receptors
E) Stimulation of serotonin receptors

---

Question 8
When initiating donepezil therapy, what is the recommended starting dose, and when should the dose be increased?

A) 10 mg/day, increase after 2 weeks
B) 5 mg/day at night, increase to 10 mg/day after 4 weeks if tolerated
C) 15 mg/day, no increase needed
D) 2 mg/day, increase to 5 mg/day after 1 week
E) 20 mg/day, increase after 1 month

---

Question 9
Which of the following side effects is specifically associated with donepezil therapy?

A) Hyperglycemia
B) Hypertension
C) Muscle cramps
D) Weight gain
E) Increased appetite

---

Question 10
If a patient on donepezil experiences difficulty sleeping, what is a recommended adjustment to the medication regimen?

A) Increase the dose immediately
B) Decrease the dose to 2.5 mg/day
C) Take the dose in the morning instead of at night
D) Add a sleep aid
E) Discontinue the medication

---

Question 11
Which of the following side effects should be closely monitored when a patient is started on donepezil?

A) Constipation and dry mouth
B) Diarrhea and nausea
C) Hyperkalemia and arrhythmias
D) Hypertension and tachycardia
E) Weight gain and increased appetite

---

Question 12
What is the primary mechanism of action of rivastigmine?

A) Selective inhibition of acetylcholinesterase
B) Non-selective, non-competitive inhibition of acetylcholinesterase and butyrylcholinesterase
C) Competitive inhibition of NMDA receptors
D) Potentiation of GABAergic neurotransmission
E) Sodium channel blockade

---

Question 13
Rivastigmine is particularly useful in managing which of the following conditions?

A) Vascular dementia
B) Alzheimer’s disease
C) Parkinson’s disease dementia and Lewy body dementia
D) Generalized anxiety disorder
E) Major depressive disorder

---

Question 14
Which of the following is a potential risk when using the transdermal patch formulation of rivastigmine?

A) Skin irritation at the application site
B) Hypertension
C) Overdose or toxicity due to applying a second patch without removing the first one
D) Increased heart rate
E) Hyperglycemia

---

Question 15
Galantamine is different from rivastigmine in that it also acts as:

A) A non-selective, non-competitive inhibitor of acetylcholinesterase
B) An allosteric modulator of nicotinic receptors
C) An irreversible inhibitor of acetylcholinesterase
D) A sodium channel blocker
E) A GABA receptor agonist

---

Question 16
Which of the following is a side effect specifically associated with galantamine?

A) Skin rash (allergy)
B) Bradycardia
C) Blurred vision
D) Hypertension
E) Dry mouth

---

Question 17
What is a key difference in the administration of rivastigmine compared to galantamine?

A) Rivastigmine is available as a transdermal patch, while galantamine is not
B) Galantamine has a longer half-life than rivastigmine
C) Rivastigmine must be taken with food, while galantamine does not
D) Galantamine is used only for Alzheimer’s, while rivastigmine is not
E) Rivastigmine requires frequent dose adjustments, while galantamine does not

---

Case 18:

A 75-year-old male with Lewy body dementia presents with increased confusion, agitation, and visual hallucinations. His son reports that the patient accidentally applied a second rivastigmine patch two days ago without removing the first. His current medications include rivastigmine (transdermal patch) and levodopa/carbidopa.

Question:
What is the most likely cause of the patient’s acute symptoms?

A) Progression of Lewy body dementia
B) Rivastigmine overdose due to improper patch use
C) Interaction between rivastigmine and levodopa/carbidopa
D) Sudden discontinuation of rivastigmine
E) Exacerbation of Parkinson’s disease

Follow-up Question 1:
What should be the immediate next step in managing this patient?

A) Remove all rivastigmine patches and monitor the patient
B) Increase the dose of levodopa/carbidopa
C) Discontinue rivastigmine permanently
D) Administer an antidote for rivastigmine
E) Start the patient on an antipsychotic to manage hallucinations

---

Case 19:

A 68-year-old woman presents to her primary care physician with her daughter, who is concerned about her mother’s recent memory issues. Over the past few months, the patient has been frequently misplacing items, forgetting appointments, and repeating the same questions multiple times. She is still able to manage her daily activities independently but has noticed difficulty in finding words during conversations. Her medical history includes hypertension, which is well-controlled with medication.

Question:
What is the most appropriate initial management strategy for this patient, given her symptoms suggest early-stage dementia?

A) Start donepezil 5 mg daily
B) Refer to a neurologist for further evaluation
C) Begin high-dose vitamin E supplementation
D) Initiate memantine therapy
E) Recommend over-the-counter memory supplements

Follow-up Question 1:
If early-stage Alzheimer’s disease is diagnosed, what is the first-line pharmacological treatment?

A) Donepezil
B) Memantine
C) Rivastigmine patch
D) Galantamine
E) None, as pharmacological treatment is not indicated in early stages

---

Case 20:

A 72-year-old male with moderate Alzheimer’s disease is brought to the pharmacy by his daughter to pick up a new prescription for donepezil. The daughter mentions that her father has been having difficulty remembering to take his medications and sometimes takes the wrong pills. She is concerned about his ability to manage his medications on his own.

Question:
What is the most appropriate counseling advice the pharmacist should give in this situation?

A) Suggest stopping the medication to avoid any confusion
B) Recommend the use of a pill organizer and set a daily routine for taking medications
C) Advise the daughter to administer the medications herself without involving her father
D) Increase the dosage to make up for missed doses
E) Recommend switching to an herbal supplement instead

Follow-up Question 1:
What additional advice should the pharmacist provide to ensure medication adherence and safety?

A) Advise on potential side effects and what to do if they occur
B) Suggest discontinuing any other medications to avoid confusion
C) Recommend the patient handle all medication management independently
D) Instruct the patient to double the dose if a dose is missed
E) Avoid discussing potential drug interactions

---

Case 21:

A 68-year-old woman with early-stage dementia is at the pharmacy with her husband, who is her primary caregiver. The pharmacist is counseling them on a new prescription for rivastigmine. The husband expresses concerns about managing the medication due to its twice-daily dosing schedule and his wife’s tendency to forget doses.

Question:
Which counseling point should the pharmacist prioritize to help the husband manage his wife’s medication regimen?

A) Suggest switching to a different medication with once-daily dosing
B) Emphasize the importance of involving the patient in every step of medication management
C) Recommend using a transdermal patch form of rivastigmine to simplify the regimen
D) Advise on crushing the pills to mix with food for easier administration
E) Focus solely on the potential side effects without addressing the dosing schedule

Follow-up Question 1:
What is another important consideration the pharmacist should discuss with the caregiver?

A) How to recognize and respond to signs of overdose, especially with patch use
B) The benefits of allowing the patient to self-administer the medication without supervision
C) The importance of rotating the application site of the patch
D) Avoiding any communication with the patient about the medication
E) Advising the caregiver to monitor for the first few doses only

---

Question 22:
Which of the following proteins is primarily associated with the pathophysiology of Alzheimer’s disease?

A) Tau protein
B) Alpha-synuclein
C) TDP-43
D) Huntingtin protein
E) Prion protein

---

Question 23:
Which of the following is NOT a common symptom of early-stage Alzheimer’s disease?

A) Difficulty remembering recent events
B) Impaired judgment
C) Severe motor dysfunction
D) Disorientation in familiar places
E) Trouble with language

---

Question 24:
Which of the following diagnostic tools is most commonly used to assess cognitive function in suspected cases of dementia?

A) Magnetic resonance imaging (MRI)
B) Mini-Mental State Examination (MMSE)
C) Positron emission tomography (PET) scan
D) Electroencephalogram (EEG)
E) Blood tests for amyloid-beta

---

Question 25:
Which of the following lifestyle changes is most strongly associated with reducing the risk of developing Alzheimer’s disease?

A) High-protein diet
B) Regular physical exercise
C) Use of dietary supplements
D) Avoiding social interactions
E) Limiting fluid intake